BiotechTube
Home/Aquavit Pharmaceuticals/Dr. Jeffrey Adelglass
DJ

Dr. Jeffrey Adelglass

Clinical Investigator

Aquavit Pharmaceuticals

Therapeutic Areas

NeuroscienceMedical AestheticsMedical DermatologyOncologyImmunology

Aquavit Pharmaceuticals Pipeline

DrugIndicationPhase
DTX-021Glabellar Lines, Periorbital Rhytids (Aesthetic); Chronic Migraine, Blepharospasm, Spasticity, Overactive Bladder (Therapeutic)Phase 3
AQT-001 (AQUAGOLD®)Device for personalized intradermal delivery of therapeutic agents for skin conditionsCommercial

Leadership Team at Aquavit Pharmaceuticals

DL
Dr. Lara Devgan
Clinical Investigator
DM
Dr. Michael Gold
Clinical Investigator
DD
Dr. David Goldberg
Clinical Investigator
DD
Dr. David Shafer
Clinical Investigator
DS
Dr. Sheila Nazarian
Clinical Investigator
DA
Dr. Ava Shamban
Clinical Investigator
View full Aquavit Pharmaceuticals profile